PrimeRx Partners with Legacy Pharmacy Group
The life sciences technology company will be able to offer services to the pharmacies associated with Legacy.
Stock.adobe.com
PrimeRx announced that it has formed a partnership with Legacy Pharmacy Group, a group purchasing organization for independent pharmacies in the New York region.1 This will provide PrimeRx, a pharmacy management software provider, with access to the more than 550 pharmacies in Legacy’s network.
In a press release, PrimeRx’s CEO Ketan Mehta said, “We are pleased to partner with the highly respected Legacy Pharmacy Group, which has a well-earned reputation for helping independent pharmacies operate at the highest levels of efficiency. Legacy pharmacies are committed to managing costs and protecting their bottom lines. PrimeRx is a natural fit for efficiency-focused pharmacies, and we look forward to introducing the system to network members.”
Legacy’s CEO Ritesh Shah also said, “This brings tremendous value to our GPO, our members will benefit from PrimeRx partnership.”
In July, PrimeRx launched PrimeRX MARKET, an online marketplace for pharmacies designed to provide competitive inventory options.2
In a press release, Mehta said, “We are thrilled to introduce PrimeRx MARKET to our solutions portfolio. PrimeRx has a strong track record of simplifying complex challenges. The drug procurement process for pharmacies, a major expense, requires precise contract compliance and inventory management to maintain cash flow and profitability. PrimeRx MARKET empowers pharmacies to source drugs intelligently and conveniently by integrating purchase and dispensing data, ensuring compliance and market agility. Our goal is to use data intelligence to streamline purchasing decisions, enabling pharmacies to remain profitable and dedicated to serving their patients."
Earlier, in June, PrimeRx announced the launch its PrimeRx Cloud technology solution, a digital platform designed specifically for independent pharmacies.3
At the time, Mehta said, “PrimeRx Cloud is the next step in pharmacy technology. We are proud to offer this addition to the PrimeRx product portfolio, which addresses the need for users to have flexibility in where, when, and how they manage their pharmacies."
In the same press release, PrimeRx’s chief technology officer Darrell Hyde said, “PrimeRx Cloud solves a number of serious problems facing today's busy pharmacies, including the need for increased flexibility and reduced IT overhead and risk. Pharmacy management no longer takes place just behind the pharmacy counter. Today's pharmacy owners are checking in from home, often long after the pharmacy has closed for the day. PrimeRx Cloud enables the modern owner to operate from anywhere while also removing the need to operate complex IT infrastructure in the pharmacy."
The company’s chief sales and marketing officer Tillmann Schwabe also said, “PrimeRx Cloud supports our goal of helping pharmacists build healthier communities. Our browser-based solution makes it easier for pharmacists to serve their patients, namely by reducing the administrative workload, which allows more time for in-person interactions."
Sources
- PrimeRx Announces Partnership with Legacy Pharmacy Group. PrimeRx. August 6, 2024. https://www.prnewswire.com/news-releases/primerx-announces-partnership-with-legacy-pharmacy-group-302213591.html
- PrimeRx Introduces PrimeRx MARKET to its Pharmacy Solutions Ecosystem. PrimeRx. July 2, 2024. Accessed August 6, 2024. https://www.prnewswire.com/news-releases/primerx-introduces-primerx-market-to-its-pharmacy-solutions-ecosystem-302187227.html
- PrimeRx Announces PrimeRx Cloud Web-Based Pharmacy Technology Solution. PrimeRx. June 25, 2024. Accessed August 6, 2024. https://www.prnewswire.com/news-releases/primerx-announces-primerx-cloud-web-based-pharmacy-technology-solution-302181998.html
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves AbbVie’s Rinvoq as First Oral JAK Inhibitor for Giant Cell Arteritis
April 30th 2025AbbVie secures FDA approval for Rinvoq as the first oral Janus kinase inhibitor indicated for giant cell arteritis, expanding its immunology portfolio and signaling strategic growth opportunities in underserved autoimmune markets.
